JP2023547889A5 - - Google Patents

Info

Publication number
JP2023547889A5
JP2023547889A5 JP2023525023A JP2023525023A JP2023547889A5 JP 2023547889 A5 JP2023547889 A5 JP 2023547889A5 JP 2023525023 A JP2023525023 A JP 2023525023A JP 2023525023 A JP2023525023 A JP 2023525023A JP 2023547889 A5 JP2023547889 A5 JP 2023547889A5
Authority
JP
Japan
Application number
JP2023525023A
Other languages
Japanese (ja)
Other versions
JP2023547889A (ja
JPWO2022093374A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/047827 external-priority patent/WO2022093374A1/en
Publication of JP2023547889A publication Critical patent/JP2023547889A/ja
Publication of JP2023547889A5 publication Critical patent/JP2023547889A5/ja
Publication of JPWO2022093374A5 publication Critical patent/JPWO2022093374A5/ja
Pending legal-status Critical Current

Links

JP2023525023A 2020-10-26 2021-08-26 脊椎融合を治療するための化合物、組成物、および使用の方法 Pending JP2023547889A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063105678P 2020-10-26 2020-10-26
US63/105,678 2020-10-26
US202163193753P 2021-05-27 2021-05-27
US63/193,753 2021-05-27
PCT/US2021/047827 WO2022093374A1 (en) 2020-10-26 2021-08-26 Compounds,compositions and methods of use to treat spinal fusions

Publications (3)

Publication Number Publication Date
JP2023547889A JP2023547889A (ja) 2023-11-14
JP2023547889A5 true JP2023547889A5 (https=) 2024-09-02
JPWO2022093374A5 JPWO2022093374A5 (https=) 2024-09-02

Family

ID=81383097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023525023A Pending JP2023547889A (ja) 2020-10-26 2021-08-26 脊椎融合を治療するための化合物、組成物、および使用の方法

Country Status (7)

Country Link
US (1) US20230390363A1 (https=)
EP (1) EP4232075A4 (https=)
JP (1) JP2023547889A (https=)
AU (1) AU2021369193A1 (https=)
CA (1) CA3196688A1 (https=)
MX (1) MX2023004829A (https=)
WO (1) WO2022093374A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019232285A1 (en) 2018-05-30 2019-12-05 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
WO2022093373A1 (en) * 2020-10-26 2022-05-05 Purdue Research Foundation Compounds,compositions and methods of use to treat bone fractures
EP4719459A1 (en) * 2023-06-01 2026-04-08 Radius Health, Inc. Methods for identification and quantitation of abaloparatide and related peptide impurities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018102616A1 (en) * 2016-11-30 2018-06-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
EP3765488A1 (en) * 2018-03-12 2021-01-20 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of pthrp analogue
WO2019232285A1 (en) * 2018-05-30 2019-12-05 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
WO2022093373A1 (en) * 2020-10-26 2022-05-05 Purdue Research Foundation Compounds,compositions and methods of use to treat bone fractures

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
JP2024506435A5 (https=)
BR112022009896A2 (https=)
JP2023547889A5 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)